Alphabet Inc.

All Holdings — 2026 Q1

AI Portfolio Summary
In 2026 Q1, Alphabet Inc. maintained a portfolio of 32 distinct positions. The most significant new addition to the portfolio was CME GROUP INC, which now represents 25.63% of the total fund value. Conversely, Alphabet Inc. completely exited their position in REPLIGEN CORP.
PCA Score Concentration Risk
Risk ENB
Total Positions
32
Quarter
2026 Q1
Top Holding
CME (25.6%)
Top 10 Concentration
94.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-32 of 32
Stock History Sector / Type Port % Prev % Rank / Prev Conviction Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
CME
CME GROUP INC
Financial Services 25.63% #1
Prev: #—
9.5 3,484,020 no change
NEW
3,484,020 $1,029,005,307 2026 Q1 13F Filing 2026-03-31 2026-05-08
PL
PLANET LABS PBC
Industrials 24.53% 24.42% #2
Prev: #2
7.5 3,306,252 10.4%
P
S
35,248,893 $985,206,582 2022 Q3 13F Filing 2026-03-31 2026-05-08
ASTS
AST SPACEMOBILE...
Technology 18.46% 25.18% #3 2
Prev: #1
6.0 no change no change
P
S
8,943,486 $741,146,685 2025 Q1 13F Filing 2026-03-31 2026-05-08
RVMD
REVOLUTION MEDI...
Healthcare 7.97% 10.33% #4 1
Prev: #3
4.2 -52,577 -1.6%
P
S
3,292,525 $320,198,056 2023 Q4 13F Filing 2026-03-31 2026-05-08
ARM
ARM HOLDINGS PL...
Technology 7.39% 8.31% #5 1
Prev: #4
4.5 no change no change
P
S
1,960,784 $296,627,404 2023 Q3 13F Filing 2026-03-31 2026-05-08
FRSH
FRESHWORKS INC
Technology 3.24% 7.70% #6 1
Prev: #5
2.3 no change no change
P
S
16,206,643 $130,139,343 2022 Q3 13F Filing 2026-03-31 2026-05-08
PATH
UIPATH INC
Technology 1.94% 4.47% #7 1
Prev: #6
1.8 no change no change
P
S
7,034,337 $78,081,141 2022 Q3 13F Filing 2026-03-31 2026-05-08
TEM
TEMPUS AI INC
Healthcare 1.75% 3.55% #8
Prev: #8
1.7 no change no change
P
S
1,551,102 $70,140,832 2024 Q2 13F Filing 2026-03-31 2026-05-08
N/A
PAYPAY CORP
Unknown 1.66% #9
Prev: #—
4.2 3,125,000 no change
NEW
3,125,000 $66,687,500 13F Filing 2026-03-31 2026-05-08
GTLB
GITLAB INC
Technology 1.47% 3.96% #10 3
Prev: #7
1.6 no change no change
P
S
2,724,712 $58,962,768 2022 Q3 13F Filing 2026-03-31 2026-05-08
PRME
PRIME MEDICINE ...
Healthcare 1.44% 2.23% #11
Prev: #11
1.6 no change no change
P
S
16,562,498 $57,637,493 2022 Q4 13F Filing 2026-03-31 2026-05-08
N/A
ETHOS TECHNOLOG...
Unknown 1.05% #12
Prev: #—
3.9 3,770,156 no change
NEW
3,770,156 $42,112,643 13F Filing 2026-03-31 2026-05-08
MAZE
MAZE THERAPEUTI...
Healthcare 1.03% 2.23% #13 3
Prev: #10
1.4 no change no change
P
S
1,388,583 $41,449,203 2025 Q1 13F Filing 2026-03-31 2026-05-08
BBOT
BRIDGEBIO ONCOL...
Healthcare 0.63% 1.37% #14 2
Prev: #12
1.3 no change no change
P
S
2,823,126 $25,266,978 2025 Q3 13F Filing 2026-03-31 2026-05-08
RLAY
RELAY THERAPEUT...
Healthcare 0.39% 0.51% #15 2
Prev: #13
0.7 -4,580 -0.3%
P
S
1,564,173 $15,563,521 2022 Q3 13F Filing 2026-03-31 2026-05-08
GLUE
MONTE ROSA THER...
Healthcare 0.28% 0.45% #16 1
Prev: #15
0.6 -60,673 -8.1%
P
S
684,275 $11,256,324 2022 Q3 13F Filing 2026-03-31 2026-05-08
VERA
VERA THERAPEUTI...
Healthcare 0.24% 0.47% #17 3
Prev: #14
1.1 no change no change
P
S
241,264 $9,706,051 2022 Q3 13F Filing 2026-03-31 2026-05-08
SANA
SANA BIOTECHNOL...
Healthcare 0.20% 0.44% #18 2
Prev: #16
1.1 no change no change
P
S
2,812,500 $8,100,000 2022 Q3 13F Filing 2026-03-31 2026-05-08
BEAM
BEAM THERAPEUTI...
Healthcare 0.19% 0.35% #19 1
Prev: #18
1.1 no change no change
P
S
321,604 $7,663,823 2022 Q3 13F Filing 2026-03-31 2026-05-08
LYEL
LYELL IMMUNOPHA...
Healthcare 0.15% 0.35% #20 3
Prev: #17
1.1 no change no change
P
S
293,256 $5,882,715 2022 Q3 13F Filing 2026-03-31 2026-05-08
OSCR
OSCAR HEALTH IN...
Healthcare 0.14% 0.27% #21 1
Prev: #20
1.1 no change no change
P
S
481,988 $5,528,402 2022 Q3 13F Filing 2026-03-31 2026-05-08
FIG
FIGMA INC
Technology 0.11% 0.31% #22 3
Prev: #19
1.0 no change no change
P
S
215,582 $4,557,403 2025 Q3 13F Filing 2026-03-31 2026-05-08
SPRO
SPERO THERAPEUT...
Healthcare 0.05% 0.08% #23
Prev: #23
1.0 no change no change
P
S
889,979 $2,082,551 2022 Q3 13F Filing 2026-03-31 2026-05-08
HYPR
HYPERFINE INC
Healthcare 0.02% 0.03% #24 1
Prev: #25
1.0 no change no change
P
S
898,720 $970,618 2022 Q3 13F Filing 2026-03-31 2026-05-08
AUTL
AUTOLUS THERAPE...
Healthcare 0.02% 0.05% #25 1
Prev: #24
1.0 no change no change
P
S
698,262 $963,602 2022 Q3 13F Filing 2026-03-31 2026-05-08
TNYA
TENAYA THERAPEU...
Healthcare 0.02% 0.03% #26
Prev: #26
1.0 no change no change
P
S
915,705 $631,836 2022 Q3 13F Filing 2026-03-31 2026-05-08
RGEN
REPLIGEN CORP
Healthcare 0.00% 0.00%
Sold All 😨
(Was: #29)
0.0 -383 -100.0%
CLOSED
$— 2022 Q3 13F Filing 2026-03-31 2026-05-08
FULC
FULCRUM THERAPE...
Healthcare 0.00% 0.01%
Sold All 😨
(Was: #28)
0.0 -14,262 -100.0%
CLOSED
$— 2022 Q3 13F Filing 2026-03-31 2026-05-08
QNCX
QUINCE THERAPEU...
Healthcare 0.00% 0.02%
Sold All 😨
(Was: #27)
0.0 -189,122 -100.0%
CLOSED
$— 2022 Q3 13F Filing 2026-03-31 2026-05-08
EXAS
EXACT SCIENCES ...
Healthcare 0.00% 0.09%
Sold All 😨
(Was: #22)
0.0 -23,205 -100.0%
CLOSED
$— 2022 Q3 13F Filing 2026-03-31 2026-05-08
WGS
GENEDX HOLDINGS...
Healthcare 0.00% 0.11%
Sold All 😨
(Was: #21)
0.0 -22,711 -100.0%
CLOSED
$— 2024 Q3 13F Filing 2026-03-31 2026-05-08
DXCM
DEXCOM INC
Healthcare 0.00% 2.67%
Sold All 😨
(Was: #9)
0.0 -1,036,937 -100.0%
CLOSED
$— 2022 Q3 13F Filing 2026-03-31 2026-05-08
Showing 1-32 of 32 holdings

Unlock Full Alphabet Inc. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics